jk

Your Replies

  • jk
      September 7, 2016 at 11:44 am

      BCBS has dozens, if not hundreds, of different plans. Not all doctors and hospitals participate with all plans. Call each place you want to go and ask them. Make sure to give your specific BCBS Plan identification name.

      And then, look up the covered providers in your exact plan. If you do not have internet access to your plan call the customer service phone number on the back of your BCBS plan card.

      jk
        June 29, 2016 at 9:00 am

        Although I did not have GBS, I did have CIDP and the symptoms of nerve pain and tingling combined with axonal induced nerve and muscle atrophy caused a change in lifestyle that literally drove me nuts.

        It is important to discuss your symptoms with your doctor and to try and determine if any of them are from the gabapentin. For example, “In Summary- Commonly reported side effects of gabapentin include: fever, fatigue, viral infection, ataxia, nystagmus, dizziness, drowsiness, and sedation. Other side effects include: tremor, blurred vision, diplopia, peripheral edema, irritability, xerostomia, and amblyopia. See below for a comprehensive list of adverse effects.”

        Jim is right. Try to be as active as you are able without aggravating your condition. Personally, I usually felt horrible on any and all of the so called ‘nerve pain’ and ‘mood’ medications. I didn’t feel better until the doctor and myself weaned me off all that Rx stuff. Like it or not, they all are designed to mess with your brain and/or your body’s natural chemical balances.

        Focus on what you are able to do. Resist the urge to dwell in the land of ‘oh, poor me, I used to be able to…..(fill in the blank).

        Look forward, positively, to your eventual recovery. Little by little.

        jk
          June 24, 2016 at 12:01 pm

          Yes, many people. One way of looking at it is is that GBS is acute. That is, it happens right now, immediately and CIDP is considered the chronic, or long lasting, version of the acute phase. One guideline is if the symptoms persist for more than 8 weeks, or return and continue, or worsen, it is considered CIDP.

          Generally speaking, treatment is the same. I recommend you read the article, on this website called ” All About CIDP.”

          here- http://www.gbs-cidp.org/cidp/all-about-cidp/

          Or, at the top of this page click on CIDP.

          jk
            June 24, 2016 at 9:45 am

            Tim, welcome and good luck. 2 things get my attention first, your question is directed at a very small sub-group. Be that as it is, the Second thing is this from elsewhere on the GBS website: “Multifocal Motor Neuropathy (MMN) is a rare condition that causes weakness without significant loss of sensation.”

            Emphasis on without loss of sensation.

            the article is here: http://www.gbs-cidp.org/variants/mmn-overview/multifocal-motor-neuropathy-mmn-progress-challenges/

            A partial answer to your question is… “E. Treatment with cyclophosphamide or human immune globulin (HIG) can produce useful functional improvement in patients with MMN. Improvement in strength after treatment with HIG (for example 1 g/kg/day x 2 days) is common (50% to 70% of cases), but the length of benefit is variable, lasting from 2 weeks to 6 or more months. The dose and frequency of subsequent treatments is based on individual patient response.”

            here: http://neuromuscular.wustl.edu/antibody/motpn2.htm

            How fast a patient recovers with treatment for multi focal motor neuropathy (mmn) lessens in importance in relation to how long the treatment is effective.

            jk
              May 28, 2016 at 6:51 pm

              United Healthcare’s Apheresis Policy is here: https://www.unitedhealthcareonline.com/ccmcontent/ProviderII/UHC/en-US/Assets/ProviderStaticFiles/ProviderStaticFilesPdf/Tools%20and%20Resources/Policies%20and%20Protocols/Medical%20Policies/Medical%20Policies/Apheresis_.pdf

              and it includes this statement: “According to the guideline, plasmapheresis is established as effective for severe acute inflammatory demyelinating polyneuropathy (AIDP)/Guillain-Barré syndrome (GBS) and in the short
              -term management of chronic inflammatory demyelinating polyneuropathy.”

              I noticed when reading both of the UHC Policies that they mention ‘..state-by-state’ considerations. You might try contacting your State Insurance Commissioner for help.

              jk
                May 28, 2016 at 6:42 pm

                I found a copy of UHC’s position paper. As you say, they take a hard core position including:
                “AND (d) Both of the following findings following lumbar puncture:
                i. White blood cell count <10/mm 3
                ii. Elevated CSF protein”

                I recommend you contact the Foundation for assistance with this battle. And, the answer is yes I did have negative spinal tap(s) as it it relates to i. and ii. above with coverage by insurance. However, my primary coverage was and is Medicare.

                jk
                  May 23, 2016 at 8:17 pm

                  I did not know what Amoxicillan/lav is. I looked it up: “Amoxicillin and clavulanate combination is an antibiotic that belongs to the group of medicines known as penicillins and beta-lactamase inhibitors. It works by killing the bacteria and preventing their growth. However, this medicine will not work for colds, flu, or other virus infections.”

                  A search at Mayo Clinic finds there may be side effects as follows: “Incidence not known- Abdominal or stomach cramps or tenderness back, leg, or stomach pains”

                  The Cleveland Clinic in a 2010 Publication on Peripheral Neuropathy reports- well see it at:

                  http://www.clevelandclinicmeded.com/medicalpubs/diseasemanagement/neurology/peripheral-neuropathy/

                  Go to Table 1. Neither amoxicillin nor clavulanate are listed as known to cause trouble.

                  I do not recollect any problems with antibiotics during my many years with CIDP. Although I also had IVIG monthly, it became necessary to have IVIG weekly, for what seemed like a long time. Your sluggishness may be CIDP related, not Rx related.

                  Be sure to report to your neurologist if these symptoms continue or worsen.

                  jk
                    May 5, 2016 at 2:21 pm

                    Suggest you re-post in Forums/CIDP because this forum is not viewed by most members.

                    Your doctor is best suited to tell you what damage you still have. Or, if you have a relapse or something new. Every case of CIDP seems to be unique and forms of CIDP will relapse. That is, get worse again.

                    jk
                      May 4, 2016 at 8:23 pm

                      C-Reactive Protein, according to the literature, is produced by the liver in response to inflammation in the body. However, CIDP is not one of the common triggers of inflammation. Some doctors might look at CRP following surgery to look for infections, or because it is an indicator of heart or blood vessel inflammation placing you at risk of heart disease or stroke.

                      hs-CRP level and heart disease risk:

                      Less than 1.0 mg/L Low risk; 1.0 to 3.0 mg/L Average risk; More than 3.0 mg/L High risk

                      A positive test means you have inflammation in the body. This may be due to a variety of conditions, including:

                      Cancer
                      Connective tissue disease
                      Heart attack
                      Infection
                      Inflammatory bowel disease (IBD)
                      Lupus
                      Pneumococcal pneumonia
                      Rheumatoid arthritis
                      Rheumatic fever
                      Tuberculosis

                      This list is not all inclusive.

                      see: https://www.nlm.nih.gov/medlineplus/ency/article/003356.htm

                      http://www.webmd.com/a-to-z-guides/c-reactive-protein-crp?page=3

                      http://www.drweil.com/drw/u/ART03424/Elevated-Creactive-Protein-CRP.html

                      The general advice given online is to improve lifestyle with a heart healthy, anti-inflammatory diet and exercise.

                      jk
                        May 2, 2016 at 7:52 pm

                        Yes, I took Alpha Lipoic Acid and many, many other things as well. Dr. Weil, a somewhat reputable medical professional says this “Take one B-100 B-complex vitamin daily. The B vitamins are necessary for normal nerve function, and supplementing is a good preventive measure. Do not take more than 200 mg of B-6, as higher daily doses can actually cause symptoms of neuropathy. Take 100 mg of alpha-lipoic acid daily. This antioxidant protects microcirculation to the nerves. You can gradually increase the dose to 300 mg twice a day over the next month.”

                        Dr. Weil makes other suggestions. here: http://www.drweil.com/drw/u/ART02717/Neuropathy.html

                        some physicians recommend Lyrica (pregabalin) Ask your doctor about being tested for your B-12 levels and if you should take additional supplements.

                        Sorry to read about your intense pain. I never did get that, only tingling and burning in my right hand.

                        jk
                          April 21, 2016 at 12:38 pm

                          I am sorry to read about your mother’s condition. There are other treatment options available.

                          For example, “In intractable cases high-dose cyclophosphamide has been shown to be effective [Gladstone et al. 2007, 2005; Brannagan et al. 2002]. We prefer an initial pulse of three cycles at 350 mg/m2 body surface followed by 600 mg/m2 body surface at an interval of every 6–8 weeks..”

                          Here: http://jnnp.bmj.com/content/76/8/1115.full

                          For more treatment options please refer to this website: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3105635/

                          If you did a search using each of the treatment methods above on this website’s search feature I am confident you will find someone who has talked about the method in the past.

                          A small measure of comfort in this data- “The 2007 GBS/CIDP Outcomes Survey indicated that over the last three decades the care of CIDP has improved the overall outcome. The mortality rate has decreased to 1.3 % and patients are less likely to be confined to a wheelchair (7 %). The proportion of patients who recovered or are independent while on treatment has increased remarkably to 31 %. Despite these improvements due to immunotherapy, the majority of cases remain to have some degree of disability with 28 % requiring an assistive device to ambulate (Koski L, 2007 CIDP Outcomes Survey, personal communication).”

                          http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3987657/

                          “Conclusions- The long term prognosis of CIDP patients was generally favourable, but 39% of patients still required immune treatments and 13% had severe disabilities. Mode of onset, distribution of symptoms, and electrophysiological characteristics may be prognostic factors for predicting a favourable outcome.”

                          http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2117396/

                          Here is another source of information: “When a patient does not respond to or cannot tolerate the first-line agents, other medications may prove beneficial. Azathioprine, cyclophosphamide, cyclosporine, interferon-alpha, interferon-beta, mycophenolate mofetil, and methotrexate have all been reported to be beneficial in CIDP patients not responsive to initial therapies.”

                          Pull up a chair to read this one- just as with your post ( a joke, please smile!)

                          http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3987657/

                          jk
                            April 15, 2016 at 6:19 pm

                            The NIH clearly says, “About 3 percent may suffer a relapse of muscle weakness and tingling sensations many years after the initial attack.”

                            Regarding the tingling you stated, “In January I began to notice a recurrence of the longest-lasting residuals:”

                            If something has ‘mostly disappeared’ and then there is a ‘noticeable recurrence’, by definition you have a relapse.

                            re·lapse (rē’laps),
                            Return of the manifestations of a disease after an interval of improvement.

                            As you state, “If i can’t walk when I wake up….” You will have waited too long to seek helpful treatment.
                            Increased tingling could be in conjunction with muscle loss which is not yet apparent.

                            jk
                              April 12, 2016 at 9:45 am

                              Regarding the reference booklet that Jim-la gave please continue to page 43 for the diagnostic criteria for CIDP.

                              And, I cast my vote with what GH said about sural nerve biopsies. They should only be done as a last and desperate attempt to make a diagnosis.

                              For example, from the Journal of Neurology and Neurosurgery & Psychiatry. 1998 Jan; 64(1): 84–89.

                              “RESULTS—The results of the first logistic analysis showed that CSF protein concentration >1 g/l (odds ratio (OR)=38.5) and neurophysiological studies consistent with demyelination (OR=51.7) were strong predictors of CIDP. When forcing the significant features and the sural nerve biopsy data into the model, an independent predictive value of sural nerve biopsy could not be found. The neurologist was able to discriminate patients with and without CIDP (area under the curve (AUC)=0.95). His diagnostic performance did not improve significantly by offering him the results of sural nerve biopsy.
                              CONCLUSION—Any additional diagnostic value of sural nerve biopsy in the diagnosis of CIDP could not be shown.”

                              jk
                                April 10, 2016 at 2:07 pm

                                You said, “Hi guys I had diagnosis of cidp from a neurologist…” What were the diagnostic criteria for the diagnosis?

                                and then, you said- “..who recommended I get started an IVIG pretty soon that was like over a month ago…”

                                If he suggested you start pretty soon, in what way did he offer to help you start? You had already seen him, therefore, you were already a patient.

                                At any rate, CSF protein levels alone neither rule in nor rule out a CIDP condition or one of it’s variants.

                                Specifically, an article in PubMed on Lewis Sumner Syndrome states- ” The CSF protein level was normal in 67% of patients and mildly elevated in the remainder.”

                                here: http://www.ncbi.nlm.nih.gov/pubmed/15289267

                                And this- ” Eighty-two percent of MADSAM neuropathy patients had elevated protein concentrations in the cerebrospinal fluid” Well, it means 18% of patients did not have elevated levels of protein.

                                In summary, you’re already unhappy with and second guessing your second neurologist. Don’t be a mind reader, wait for his diagnosis and treatment plan.

                                Or, go find somebody you will be happy with.

                                For what my history is worth, every single Doctor I saw repeated every single test. It’s part and parcel of the medical side of things. Further, it is required to rule in and to rule out all kinds of disseases for this condition.

                                jk
                                  April 6, 2016 at 1:43 pm

                                  A blood patch, in this case, is used to treat the patient’s ‘leaking’ lumbar puncture site by inserting some autologous blood back into the area of the original puncture and letting the blood clot thus stopping the leak.

                                  http://www.webmd.com/pain-management/pain-management-spinal-headaches